Premium Medical Services Limited 04340857 false 2023-06-01 2024-05-31 2024-05-31 The principal activity of the company is that of sourcing medical consultants, organising appointments and obtaining reports for use in legal cases Digita Accounts Production Advanced 6.30.9574.0 true 04340857 2023-06-01 2024-05-31 04340857 2024-05-31 04340857 core:CurrentFinancialInstruments core:WithinOneYear 2024-05-31 04340857 bus:Micro-entities 2023-06-01 2024-05-31 04340857 bus:AuditExemptWithAccountantsReport 2023-06-01 2024-05-31 04340857 bus:FilletedAccounts 2023-06-01 2024-05-31 04340857 bus:SmallCompaniesRegimeForAccounts 2023-06-01 2024-05-31 04340857 bus:RegisteredOffice 2023-06-01 2024-05-31 04340857 bus:Director3 2023-06-01 2024-05-31 04340857 bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 04340857 countries:EnglandWales 2023-06-01 2024-05-31 04340857 2022-06-01 2023-05-31 04340857 2023-05-31 04340857 core:CurrentFinancialInstruments core:WithinOneYear 2023-05-31 iso4217:GBP xbrli:pure

Registration number: 04340857

Prepared for the registrar
 

Premium Medical Services Limited

Unaudited Financial Statements

for the Year Ended 31 May 2024

 

Premium Medical Services Limited

(Registration number: 04340857)
Balance Sheet as at 31 May 2024

2024
£

2023
£

Current assets

645,894

635,549

Creditors: Amounts falling due within one year

(634,328)

(631,189)

Total assets less current liabilities

11,566

4,360

Accruals and deferred income

(5,860)

(5,623)

 

5,706

(1,263)

Capital and reserves

5,706

(1,263)

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
481 Lordship Lane
Dulwich
London
SE22 8JY

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Staff numbers

The average number of persons employed by the company (including directors) during the year, was as follows:

At 31 May 2024, the company was owed £341,549 (2023 - £331,968) by AW Anderson in the form of a director’s
loan account. The loan has no fixed repayment terms and interest is payable on the loan.

At 31 May 2024, the company was owed £26,649 (2023 - £26,063) by S Wixted in the form of a director’s
loan account. The loan has no fixed repayment terms and interest is payable on the loan.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

 

Premium Medical Services Limited

(Registration number: 04340857)
Balance Sheet as at 31 May 2024

For the financial year ending 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Approved and authorised by the Board on 26 February 2025 and signed on its behalf by:
 

.........................................
S L Wixted
Director